4507 Stock Overview
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4507 from our risk checks.
Shionogi & Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥6,690.00 |
| 52 Week High | JP¥8,137.00 |
| 52 Week Low | JP¥5,834.00 |
| Beta | 0.36 |
| 11 Month Change | -1.70% |
| 3 Month Change | -4.10% |
| 1 Year Change | 3.07% |
| 33 Year Change | -5.11% |
| 5 Year Change | 17.68% |
| Change since IPO | 609.44% |
Recent News & Updates
Shionogi (TSE:4507) Will Pay A Dividend Of ¥85.00
Aug 28
Shionogi's (TSE:4507) Dividend Will Be ¥85.00
Aug 09Shionogi & Co., Ltd. Just Missed EPS By 20%: Here's What Analysts Think Will Happen Next
Jul 31Shionogi (TSE:4507) Will Pay A Dividend Of ¥85.00
Jul 26Recent updates
Shionogi (TSE:4507) Will Pay A Dividend Of ¥85.00
Aug 28Shionogi's (TSE:4507) Dividend Will Be ¥85.00
Aug 09Shionogi & Co., Ltd. Just Missed EPS By 20%: Here's What Analysts Think Will Happen Next
Jul 31Shionogi (TSE:4507) Will Pay A Dividend Of ¥85.00
Jul 26Shionogi (TSE:4507) Will Pay A Dividend Of ¥85.00
Jul 11Shionogi's (TSE:4507) Soft Earnings Don't Show The Whole Picture
Jun 28Is Shionogi & Co., Ltd. (TSE:4507) Trading At A 28% Discount?
May 07Shionogi & Co., Ltd.'s (TSE:4507) Shares May Have Run Too Fast Too Soon
Mar 22Shionogi (TSE:4507) Will Pay A Dividend Of ¥75.00
Mar 01Shareholder Returns
| 4507 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.3% | 3.4% | 1.3% |
| 1Y | 3.1% | 20.8% | 14.6% |
Return vs Industry: 4507 underperformed the JP Pharmaceuticals industry which returned 19.8% over the past year.
Return vs Market: 4507 underperformed the JP Market which returned 14.7% over the past year.
Price Volatility
| 4507 volatility | |
|---|---|
| 4507 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 10.1% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 4507 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4507's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1878 | 4,959 | Isao Teshirogi | www.shionogi.com |
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19.
Shionogi & Co., Ltd. Fundamentals Summary
| 4507 fundamental statistics | |
|---|---|
| Market cap | JP¥1.90t |
| Earnings (TTM) | JP¥150.11b |
| Revenue (TTM) | JP¥423.36b |
12.6x
P/E Ratio4.5x
P/S RatioIs 4507 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4507 income statement (TTM) | |
|---|---|
| Revenue | JP¥423.36b |
| Cost of Revenue | JP¥58.93b |
| Gross Profit | JP¥364.43b |
| Other Expenses | JP¥214.33b |
| Earnings | JP¥150.11b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 28, 2024
| Earnings per share (EPS) | 529.49 |
| Gross Margin | 86.08% |
| Net Profit Margin | 35.46% |
| Debt/Equity Ratio | 0% |
How did 4507 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield31%
Payout RatioDoes 4507 pay a reliable dividends?
See 4507 dividend history and benchmarks| Shionogi dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 29 days |
| Days until Dividend pay date | 95 days |
Does 4507 pay a reliable dividends?
See 4507 dividend history and benchmarks